Insider holders · CIK 0001869105
BridgeBio Oncology Therapeutics, Inc. · BBOT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Bihua ChenDirector | — | 1,905,046 | 1,905,046 | Jul 6, 2026 · 4:34 pm EDT | Form 4 |
| Pedro BeltranPresident and CEO | 44,576 | — | 44,576 | Jul 6, 2026 · 6:00 pm EDT | Form 4 |
| Yong BenChief Med & Dev Officer | 44,576 | — | 44,576 | Jul 6, 2026 · 6:00 pm EDT | Form 4 |
| Idan ElmelechCOO & Principal Financial Ofcr | 14,495 | — | 14,495 | Jul 6, 2026 · 6:00 pm EDT | Form 4 |
| Marc CoboPrincipal Accounting Officer | 14,141 | — | 14,141 | Sep 14, 2026 · 4:24 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.